China Medical Technologies Inc: Company Report
No. 24 Yong Chang North Road
Beijing Tech. Development Area
Beijing BEJ 100176
http://www.chinameditech.com/ - Phone: 10-65308833
- Fax: 10-65309733
- Industry : Medical Instruments & Supplies
- Employees : 733
- Exchange : NASDAQ
China Medical Technologies, Inc. (China Medical) is a People’s Republic of China-based medical device company, which develops, manufactures and markets advanced immunodiagnostic and molecular diagnostic products utilizing enhanced chemiluminescence immunoassay (ECLIA) technology, fluorescent in situ hybridization (FISH) technology and surface plasmon resonance (SPR) technology. The in-vitro diagnostics (IVD) products are used to detect and monitor various diseases and disorders through laboratory evaluation and analysis of blood, urine or other body fluids. The Company operates in two business segments: immunodiagnostic systems and molecular diagnostic systems. Immunodiagnostic systems include ECLIA analyzers and reagent kits. The molecular diagnostic systems include FISH imaging analyzers and probes. It also includes SPR systems and human papillomavirus- deoxyribonucleic acid (HPV-DNA) chips. The wholly owned subsidiary of the Company is CMED ECLIA Diagnostic Technology Ltd.
| Stock Activity |
|---|
|
Last Price |
12.67 |
|
52 Week High |
26.07 |
|
52 Week Low |
11.41 |
|
Volume |
810,145 |
|
Average Daily Volume (13wk) |
835,193 |
| fyi |
50 Day Moving Average |
16.01 |
|
200 Day Moving Average |
17.42 |
|
Volatility (beta) |
1.21 |
| Stock Price History |
|---|
| | Change | Relative Strength |
|---|
|
Last 3 Months |
-24.2% |
13 |
|
Last 6 Months |
-35.4% |
10 |
|
Last 12 Months |
-32.4% |
13 |
Historical charts
| Institutional Statistics |
|---|
| Analyst Consensus | Hold | | Institutional Ownership | 4.80% |
More Analyst Ratings
Want to learn how to evaluate a stock? Walk through the steps using the Research Wizard. | advertisement
| Financials |
|---|
| | Last 12 Months | 5 Year Growth |
|---|
|
Sales |
128.4 Mil |
49.6% |
|
Income |
-6.9 Mil |
NA |
| fyi |
Dividend Rate |
0.55 |
NA |
|
Dividend Yield |
4.24% |
NA |
More financials
| Fundamental Data |
|---|
| Debt/Equity Ratio | 1.54 | | Gross Margin | 73.40% | | Net Profit Margin | -5.36% | | Total Shares Outstanding | 32.1 Mil | | Market Capitalization | 406.79 Mil | | Earnings/Share | 1.48 |
More financial ratios
| Earnings Estimates
|
|---|
| Qtr(12/09) EPS Estimate |
NA |
| FY(3/10) EPS Estimate |
1.52 |
| Current P/E |
NA |
| FY(3/11) EPS Estimate |
1.66 |
| Forward P/E |
7.63 |
| Next Earnings Release:
N/A | | More analyst estimates
|
Recent News